Archive for the 'Bristol-Myers Squibb' Category

Bristol-Myers Squibb news feed.

Opdivo and MTG201 Together Could Potentially Treat Mesothelioma

Typical cancer treatments are hard on the body and are not always effective. When treating someone for cancer, chemotherapy is typically used, which kills cancer cells or stops them from growing or spreading. Chemotherapy can also kill healthy cells, which makes it hard on the body. Immunotherapy is another option, and it works by helping

more

Opdivo, Yervoy, and Keytruda: Immunotherapy Options for Mesothelioma

Immunotherapy treatments are becoming known alternatives to chemotherapy in cancer patients who have had little success with traditional cancer treatments. With mesothelioma, often times first line treatments have little effect because the cancer is typically in the advanced stages by the time it is detected.  While there currently is no cure for mesothelioma, scientists and

more

ERBITUX–Cetuximab–Receives FDA Approval to Treat Irinotecan Refractory or Intolerant Metastatic Colorectal Cancer; First-of-its-Kind Antibody Approved for Use in Combination with Irinotecan and As a Single Agent

Related News 2 drugs open a new front in cancer war: Avastin, Erbitux herald revolution that targets cells (free membership required) – March 2, 2004 (Judy Peres, Chicago Tribune). QUOTE:“‘We’re in a new era of drug development for cancer,’ said Dr. Hedy Kindler, director of gastrointestinal oncology at the University of Chicago who has tested

more

Last update: April 01, 2019. 03:30:08 pm.